Table 2

Independent predictors for death from any cause at 1 year

HR (95% CIs)*χ2p Value
Total population
 NT-proBNP (by 1000 ng/L)1.04 (1.02 to 1.05)47.6<0.001
 Serum sodium (by 10 mmol/L)0.60 (0.47 to 0.76)19.4<0.001
 Diastolic blood pressure (by 10 mm Hg)0.86 (0.78 to 0.93)15.6<0.001
 Obesity (body mass index ≥23 kg/m2)1.50 (1.11 to 2.03)7.40.009
 Previous myocardial infarction1.55 (1.11 to 2.17)6.10.011
HFpEF population
 NT-proBNP (by 1000 ng/L)1.05 (1.03 to 1.07)25.1<0.001
 Obesity (body mass index ≥23 kg/m2)1.91 (1.08 to 3.39)4.70.026
HFrEF population
 NT-proBNP (by 1000 ng/L)1.03 (1.01 to 1.05)24.5<0.001
 Diastolic blood pressure (by 10 mm Hg)0.80 (0.71 to 0.90)18.3<0.001
 Serum sodium (by 10 mmol/L)0.56 (0.40 to 0.80)10.20.001
 Previous myocardial infarction2.07 (1.37 to 3.11)10.30.001
 Obesity (body mass index ≥23 kg/m2)1.73 (1.15 to 2.62)7.10.009
  • *Multivariable model was constructed with the Cox proportional hazard model using forward selection method (Wald statistic). Input variables were age, sex, diabetes, hypertension, chronic renal failure, chronic lung disease, valvular heart disease, peripheral artery disease, history of myocardial infarction, stroke, current smoking status, New York Heart Association functional class, systolic blood pressure, diastolic blood pressure, heart rate, atrial fibrillation, haemoglobin, serum sodium, LVEF and plasma level of NT-proBNP.

  • HF, heart failure; HFpEF, heart failure with preserved EF (≥50%); HFrEF, heart failure with reduced EF (≤40%); NT-proBNP, N-terminal–pro-brain natriuretic peptide.